{"id":"https://openalex.org/W4415734018","doi":"https://doi.org/10.1016/j.ijpharm.2026.126944","title":"Exploring the impact of nucleotide length on lipid nanoparticle structure and properties","display_name":"Exploring the impact of nucleotide length on lipid nanoparticle structure and properties","publication_year":2026,"publication_date":"2026-05-01","ids":{"openalex":"https://openalex.org/W4415734018","doi":"https://doi.org/10.1016/j.ijpharm.2026.126944","pmid":"https://pubmed.ncbi.nlm.nih.gov/42070739"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2026.126944","doi":"https://doi.org/10.1016/j.ijpharm.2026.126944","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2026.126944","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ijpharm.2026.126944","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032701796","display_name":"Michal Hammel","orcid":"https://orcid.org/0000-0002-5610-9289","observed_orcids":["https://orcid.org/0000-0002-5610-9289"]},"institutions":[{"id":"https://openalex.org/I148283060","display_name":"Lawrence Berkeley National Laboratory","ror":"https://ror.org/02jbv0t02","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I148283060","https://openalex.org/I39565521"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michal Hammel","raw_affiliation_strings":["Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Lab, Berkeley, CA, USA. Electronic address: mhammel@lbl.gov"],"raw_orcid":"https://orcid.org/0000-0002-5610-9289","affiliations":[{"raw_affiliation_string":"Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Lab, Berkeley, CA, USA. Electronic address: mhammel@lbl.gov","institution_ids":["https://openalex.org/I148283060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102734435","display_name":"Yuchen Fan","orcid":"https://orcid.org/0000-0001-7868-2919","observed_orcids":["https://orcid.org/0000-0001-7868-2919"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuchen Fan","raw_affiliation_strings":["Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0001-7868-2919","affiliations":[{"raw_affiliation_string":"Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046364084","display_name":"Lee Joon Kim","orcid":"https://orcid.org/0000-0002-0786-7614","observed_orcids":["https://orcid.org/0000-0002-0786-7614"]},"institutions":[{"id":"https://openalex.org/I148283060","display_name":"Lawrence Berkeley National Laboratory","ror":"https://ror.org/02jbv0t02","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I148283060","https://openalex.org/I39565521"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lee Joon Kim","raw_affiliation_strings":["Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Lab, Berkeley, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Lab, Berkeley, CA, USA","institution_ids":["https://openalex.org/I148283060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062906133","display_name":"Nanzhi Zang","orcid":"https://orcid.org/0000-0001-6438-7302","observed_orcids":["https://orcid.org/0000-0001-6438-7302"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nanzhi Zang","raw_affiliation_strings":["Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005429817","display_name":"Baixue Xiao","orcid":"https://orcid.org/0000-0001-8337-8401","observed_orcids":["https://orcid.org/0000-0001-8337-8401"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Baixue Xiao","raw_affiliation_strings":["Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019445946","display_name":"Antonino Cali\u00f2","orcid":"https://orcid.org/0000-0003-2324-2902","observed_orcids":["https://orcid.org/0000-0003-2324-2902"]},"institutions":[{"id":"https://openalex.org/I148283060","display_name":"Lawrence Berkeley National Laboratory","ror":"https://ror.org/02jbv0t02","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I148283060","https://openalex.org/I39565521"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonino Calio","raw_affiliation_strings":["Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Lab, Berkeley, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-2324-2902","affiliations":[{"raw_affiliation_string":"Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Lab, Berkeley, CA, USA","institution_ids":["https://openalex.org/I148283060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016901482","display_name":"Chun\u2010Wan Yen","orcid":"https://orcid.org/0000-0002-8222-335X","observed_orcids":["https://orcid.org/0000-0002-8222-335X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chun-Wan Yen","raw_affiliation_strings":["Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA. Electronic address: Yen.Chunwan@gene.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA. Electronic address: Yen.Chunwan@gene.com","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042886731","display_name":"Greg L. Hura","orcid":"https://orcid.org/0000-0003-0501-8464","observed_orcids":["https://orcid.org/0000-0003-0501-8464"]},"institutions":[{"id":"https://openalex.org/I148283060","display_name":"Lawrence Berkeley National Laboratory","ror":"https://ror.org/02jbv0t02","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I148283060","https://openalex.org/I39565521"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Greg L. Hura","raw_affiliation_strings":["Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Lab, Berkeley, CA, USA. Electronic address: glhura@lbl.gov"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Lab, Berkeley, CA, USA. Electronic address: glhura@lbl.gov","institution_ids":["https://openalex.org/I148283060"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5016901482","https://openalex.org/A5032701796","https://openalex.org/A5042886731"],"corresponding_institution_ids":["https://openalex.org/I148283060","https://openalex.org/I183934855"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":{"value":4650,"currency":"USD","value_usd":4650},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00702081,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"698","issue":null,"first_page":"126944","last_page":"126944"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.9980000257492065},{"id":"https://openalex.org/keywords/inverted-hexagonal-phase","display_name":"inverted hexagonal phase","score":0.9139999747276306},{"id":"https://openalex.org/keywords/lamellar-phase","display_name":"lamellar phase","score":0.9900000095367432},{"id":"https://openalex.org/keywords/payload-capacity","display_name":"payload capacity","score":0.5130000114440918},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.8989999890327454},{"id":"https://openalex.org/keywords/nucleic-acid-therapeutics","display_name":"nucleic acid therapeutics","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C24107716","wikidata":"https://www.wikidata.org/wiki/Q123619","display_name":"Nucleic acid","level":2,"score":0.5985000133514404},{"id":"https://openalex.org/C131888329","wikidata":"https://www.wikidata.org/wiki/Q3027679","display_name":"Small-angle X-ray scattering","level":3,"score":0.5888000130653381},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5629000067710876},{"id":"https://openalex.org/C77851909","wikidata":"https://www.wikidata.org/wiki/Q6481705","display_name":"Lamellar structure","level":2,"score":0.5333999991416931},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.5022000074386597},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.47049999237060547},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.38530001044273376},{"id":"https://openalex.org/C128765274","wikidata":"https://www.wikidata.org/wiki/Q663314","display_name":"Hexagonal crystal system","level":2,"score":0.38109999895095825},{"id":"https://openalex.org/C195065555","wikidata":"https://www.wikidata.org/wiki/Q214881","display_name":"Curvature","level":2,"score":0.375900000333786},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.3684000074863434},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.3440999984741211},{"id":"https://openalex.org/C159467904","wikidata":"https://www.wikidata.org/wiki/Q2001702","display_name":"Chemical physics","level":1,"score":0.3393000066280365},{"id":"https://openalex.org/C77993745","wikidata":"https://www.wikidata.org/wiki/Q3072364","display_name":"Shape factor","level":2,"score":0.33079999685287476},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.3301999866962433},{"id":"https://openalex.org/C2780134926","wikidata":"https://www.wikidata.org/wiki/Q5748761","display_name":"Hexagonal phase","level":3,"score":0.3084000051021576},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.30730000138282776},{"id":"https://openalex.org/C174576160","wikidata":"https://www.wikidata.org/wiki/Q1183700","display_name":"Deconvolution","level":2,"score":0.3059999942779541},{"id":"https://openalex.org/C110455231","wikidata":"https://www.wikidata.org/wiki/Q897788","display_name":"Compartmentalization (fire protection)","level":3,"score":0.30329999327659607},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.28940001130104065},{"id":"https://openalex.org/C512185932","wikidata":"https://www.wikidata.org/wiki/Q28745","display_name":"Nucleotide","level":3,"score":0.27570000290870667},{"id":"https://openalex.org/C2777278457","wikidata":"https://www.wikidata.org/wiki/Q6815124","display_name":"Membrane curvature","level":4,"score":0.2743000090122223},{"id":"https://openalex.org/C177418412","wikidata":"https://www.wikidata.org/wiki/Q18344920","display_name":"Lamellar phase","level":3,"score":0.2515999972820282}],"mesh":[{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009696","descriptor_name":"Nucleic Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D009711","descriptor_name":"Nucleotides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014961","descriptor_name":"X-Ray Diffraction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020285","descriptor_name":"Cryoelectron Microscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D053838","descriptor_name":"Scattering, Small Angle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ijpharm.2026.126944","doi":"https://doi.org/10.1016/j.ijpharm.2026.126944","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2026.126944","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"doi:10.2139/ssrn.5670368","doi":"https://doi.org/10.2139/ssrn.5670368","is_oa":true,"landing_page_url":"https://doi.org/10.2139/ssrn.5670368","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmid:42070739","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42070739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ijpharm.2026.126944","doi":"https://doi.org/10.1016/j.ijpharm.2026.126944","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2026.126944","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G30714459","display_name":null,"funder_award_id":"DE-AC02-05CH11231.","funder_id":"https://openalex.org/F4320337480","funder_display_name":"Basic Energy Sciences"},{"id":"https://openalex.org/G554592630","display_name":null,"funder_award_id":"CA92584","funder_id":"https://openalex.org/F4320338333","funder_display_name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute"},{"id":"https://openalex.org/G9000875362","display_name":"ALS Efficiently Networking Advanced Beam Line Experiments (ALS-ENABLE)","funder_award_id":"P30GM124169","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320306084","display_name":"U.S. Department of Energy","ror":"https://ror.org/01bj3aw27"},{"id":"https://openalex.org/F4320309434","display_name":"University of Wisconsin-Madison","ror":"https://ror.org/01y2jtd41"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337480","display_name":"Basic Energy Sciences","ror":"https://ror.org/05mg91w61"},{"id":"https://openalex.org/F4320337509","display_name":"Biological and Environmental Research","ror":"https://ror.org/0114b2m14"},{"id":"https://openalex.org/F4320338333","display_name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","ror":"https://ror.org/00vkwep27"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W222303975","https://openalex.org/W2022488218","https://openalex.org/W2065197899","https://openalex.org/W2095613974","https://openalex.org/W2106704490","https://openalex.org/W2285881370","https://openalex.org/W2794867971","https://openalex.org/W2795918326","https://openalex.org/W2914060533","https://openalex.org/W3006764150","https://openalex.org/W3036363721","https://openalex.org/W3048788919","https://openalex.org/W3080784905","https://openalex.org/W3083301834","https://openalex.org/W3088467904","https://openalex.org/W3091724054","https://openalex.org/W3097642783","https://openalex.org/W3111774194","https://openalex.org/W3131574721","https://openalex.org/W3154719862","https://openalex.org/W3188661591","https://openalex.org/W3212311097","https://openalex.org/W4210772166","https://openalex.org/W4296833728","https://openalex.org/W4308293505","https://openalex.org/W4313622517","https://openalex.org/W4328107217","https://openalex.org/W4376272836","https://openalex.org/W4377289107","https://openalex.org/W4379600656","https://openalex.org/W4382047482","https://openalex.org/W4387373872","https://openalex.org/W4387865367","https://openalex.org/W4388752499","https://openalex.org/W4390577909","https://openalex.org/W4391144896","https://openalex.org/W4391322999","https://openalex.org/W4391741660","https://openalex.org/W4393092735","https://openalex.org/W4393169399","https://openalex.org/W4401059285","https://openalex.org/W4401103334","https://openalex.org/W4401627951","https://openalex.org/W4404434178","https://openalex.org/W4405894118","https://openalex.org/W4405969761","https://openalex.org/W4409258159","https://openalex.org/W4411399363","https://openalex.org/W4412795195","https://openalex.org/W4412805307","https://openalex.org/W4415464673"],"related_works":["https://openalex.org/W7130558884","https://openalex.org/W4410975532","https://openalex.org/W4414160096","https://openalex.org/W4328107217","https://openalex.org/W4390619935","https://openalex.org/W4410445707","https://openalex.org/W4408537612","https://openalex.org/W4417101151","https://openalex.org/W7163377008","https://openalex.org/W4319869430"],"abstract_inverted_index":{"Lipid":[0],"nanoparticles":[1],"(LNPs)":[2],"are":[3],"versatile":[4],"carriers":[5],"for":[6,147],"nucleic":[7,153],"acid":[8,154],"(NA)":[9],"therapeutics,":[10],"including":[11],"ASOs,":[12],"siRNA,":[13],"mRNA,":[14],"and":[15,33,51,63,81,115],"poly-IC.":[16],"While":[17],"lipid":[18,52],"composition":[19,53],"is":[20,36],"known":[21],"to":[22],"influence":[23],"LNP":[24,149],"properties,":[25],"the":[26,41,121,127],"impact":[27],"of":[28,43,129],"NA":[29,49,137],"length":[30,50],"on":[31],"morphology":[32],"internal":[34],"structure":[35],"less":[37],"understood,":[38],"particularly":[39],"during":[40],"stages":[42],"carrier\u2013cargo":[44],"assembly.":[45],"Here,":[46],"we":[47],"examine":[48],"immediately":[54],"after":[55],"mixing":[56],"using":[57],"high-throughput":[58],"SAXS,":[59],"dynamic":[60],"light":[61],"scattering,":[62],"cryogenic":[64],"electron":[65],"microscopy.":[66],"All":[67],"LNPs":[68],"form":[69],"ordered":[70,100],"NA/lipid":[71],"compartments,":[72],"with":[73,112],"longer":[74],"NAs":[75],"promoting":[76],"inverse":[77],"hexagonal":[78],"(HII)":[79],"phases":[80,103],"larger":[82],"intercompartment":[83],"distances.":[84],"In":[85],"contrast,":[86],"short":[87],"NAs,":[88],"especially":[89],"in":[90,132,136,141],"SM102":[91],"formulations,":[92],"favor":[93],"lamellar":[94],"phases.":[95],"SAXS":[96],"peak":[97],"deconvolution":[98],"quantifies":[99],"versus":[101],"disordered":[102],"via":[104],"a":[105,145],"Phase":[106],"Quality":[107],"Factor":[108],"(Q-factor),":[109],"which":[110],"correlates":[111],"particle":[113],"size":[114],"encapsulation":[116],"efficiency.":[117],"MC3/DOPE":[118],"formulations":[119],"exhibit":[120],"most":[122],"stable":[123],"HII-phase":[124],"packing,":[125],"highlighting":[126],"role":[128],"helper-lipid":[130],"curvature":[131],"compartment":[133],"stabilization.":[134],"Variations":[135],"compartmentalization":[138],"indicate":[139],"differences":[140],"payload":[142],"capacity,":[143],"offering":[144],"framework":[146],"rational":[148],"design":[150],"across":[151],"diverse":[152],"cargos.":[155]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-10-31T00:00:00"}